Therapy for HER2-Positive Metastatic Breast Cancer
N Engl J Med
.
2020 Jun 18;382(25):e98.
doi: 10.1056/NEJMc2004854.
Author
Tim J A Dekker
1
Affiliation
1
Haaglanden Medisch Centrum, The Hague, the Netherlands t.j.a.dekker@gmail.com.
PMID:
32558479
DOI:
10.1056/NEJMc2004854
No abstract available
Publication types
Letter
Comment
MeSH terms
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms*
Capecitabine
Humans
Receptor, ErbB-2
Trastuzumab
Substances
Capecitabine
Receptor, ErbB-2
Trastuzumab